Phase II study of prolonged oral etoposide in refractory ovarian cancer | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Original Articles

Phase II study of prolonged oral etoposide in refractory ovarian cancer

Online download statistics by month:

Online download statistics by month: January 2019 to March 2023

	Abstract	Full	Pdf
Jan 2019	8	0	0
Feb 2019	17	0	1
Mar 2019	10	0	1
Apr 2019	10	0	0
May 2019	9	0	0
Jun 2019	7	0	0
Jul 2019	8	0	0
Aug 2019	8	0	0
Sep 2019	8	0	3
Oct 2019	6	0	3
Nov 2019	2	0	0
Dec 2019	8	0	0
Jan 2020	16	0	0
Feb 2020	6	0	0
Mar 2020	3	0	0
Apr 2020	3	0	0
May 2020	18	0	0
Jun 2020	6	0	0
Jul 2020	8	0	0
Aug 2020	10	0	0
Sep 2020	16	0	0
Oct 2020	11	0	1
Nov 2020	11	0	0
Dec 2020	6	0	0
Jan 2021	4	0	0
Feb 2021	2	0	0
Mar 2021	14	0	0
Apr 2021	2	0	0
Oct 2021	15	0	0
Nov 2021	10	0	2
Dec 2021	4	0	0
Jan 2022	21	0	1
Feb 2022	8	0	0
Mar 2022	16	0	0
Apr 2022	13	0	0
May 2022	36	0	0
Jun 2022	43	0	0
Jul 2022	16	0	0
Aug 2022	52	0	0
Sep 2022	34	0	0
Oct 2022	38	0	0
Nov 2022	30	0	1
Dec 2022	12	0	1
Jan 2023	24	0	1
Feb 2023	56	0	1
Mar 2023	26	0	3
Total	691	0	19